On Tuesday, July 6, 2022, the Brazilian National Congress analysed Presidential Veto No. 48, which provides for the compulsory license of patents...
OUR TEAM
Roberto Ribeiro
Partner
Roberto Ribeiro is a civil engineer and lawyer with an MBA in Business Administration. He is currently responsible for the development of new protection and management strategies for patent portfolios, including licensing of various technologies.”
Roberto has been working in Intellectual Property for over 33 years, having obtained in-house experience in several sectors such as mechanics and metallurgy, pharmaceutical, beverages, personal care and cosmetic products (CHC).
He has overseen IP for large corporations in many fronts, having been primarily responsible for such topics in Latin America, Japan, Africa and Eastern Europe.
In his last role before joining Daniel Law, Roberto spent over a decade working as an Associate Vice-President for a French multinational pharmaceutical company.
Pratice Areas
Intellectual property, M&A, civil litigation, regulatory affairs in cosmetics, food and personal care products (CHC) sectors and competition law.
Education
Law degree from Ibirapuera University;
Post-graduation in Business Administration from Mackenzie Presbyterian University;
Graduated in Civil Engineering from the University of Vale da Paraíba.
Post-graduation in Business Administration from Mackenzie Presbyterian University;
Graduated in Civil Engineering from the University of Vale da Paraíba.
Affiliations, Commissions and Collegiate
Admitted to the Brazilian Bar Association, São Paulo section;
Member of the Brazilian Intellectual Property Association – ABPI.
Member of the Brazilian Intellectual Property Association – ABPI.
Articles
WTO approves patent waiver for Covid-19 vaccines
On June 17 of 2022, the World Trade Organization announced that member countries agreed to a patent waiver covering Covid-19 vaccines. The decision...
Tech Roundup: Patent delays deter innovation in Brazil
The main news about tech and innovation in Brazil. This week: patent delays, instant payments, real estate startups This week. WIPO claims Brazil...
Coronavirus and IP – Is it time for a reflection about the patent system? Or about the life science first?
During my recent attendance at the MIP – Managing Intellectual Property, International Patent Forum 2020 in London early this month, which Daniel...
How to patent second medical uses in Brazil
Increasingly important to life sciences innovation, the repurposing of existing drugs is not patentable in some major developing markets. While the...
Brazil’s first national IP strategy heralds benefits for biopharma innovators
A draft for what will be Brazil’s first comprehensive national strategy for IP policy has been published by the country’s government, with a view to...
The Permanent War
“Whoever is first in the field and awaits the coming of the enemy, will be fresh for the fight; whoever is second in the field and has to hasten to...